Literature DB >> 20031289

Relationship of synovial tumor necrosis factor alpha and interleukin 6 to temporomandibular disorder.

Jeong Keun Lee1, Young Sook Cho, Seung Il Song.   

Abstract

PURPOSE: The purpose of this study was to elucidate the relationship of tumor necrosis factor alpha (TNF-alpha) and interleukin 6 (IL-6) to temporomandibular disorder with clinical symptoms such as pain, joint sounds, and mouth opening limitation by analysis of the level of these molecules in the synovial fluid. PATIENTS AND METHODS: Twenty-four patients with chief complaints of pain, mouth opening limitation, and clicking sounds were selected as the experimental group and compared with 5 healthy subjects. After joint lavage with arthrocentesis, diluted synovial fluid was collected and enzyme-linked immunosorbent assay was done for analysis of TNF-alpha and IL-6 in 24 experimental patients and 5 healthy subjects.
RESULTS: The synovial levels of TNF-alpha and IL-6 were elevated in the experimental group compared with the healthy control group, but no significant correlation was established. The synovial levels of TNF-alpha and IL-6 were elevated in the acute pain group compared with the chronic pain group, but no significant correlation was established.
CONCLUSION: In our analysis of 2 proinflammatory cytokines, TNF-alpha and IL-6, in the synovial fluid of temporomandibular disorder patients with symptoms of pain, mouth opening limitation, and clicking, both were elevated without statistical significance. Copyright 2010 American Association of Oral and Maxillofacial Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20031289     DOI: 10.1016/j.joms.2009.08.007

Source DB:  PubMed          Journal:  J Oral Maxillofac Surg        ISSN: 0278-2391            Impact factor:   1.895


  11 in total

1.  Sexual dimorphism on cytokines expression in the temporomandibular joint: the role of gonadal steroid hormones.

Authors:  Karla E Torres-Chávez; Luana Fischer; Juliana Maia Teixeira; Nadia Cristina Fávaro-Moreira; Gustavo Alberto Obando-Pereda; Carlos Amílcar Parada; Claudia Herrera Tambeli
Journal:  Inflammation       Date:  2011-10       Impact factor: 4.092

Review 2.  Perspectives on next steps in classification of oro-facial pain - Part 3: biomarkers of chronic oro-facial pain - from research to clinic.

Authors:  W Ceusters; C Nasri-Heir; D Alnaas; B E Cairns; A Michelotti; R Ohrbach
Journal:  J Oral Rehabil       Date:  2015-07-22       Impact factor: 3.837

3.  Infliximab partially alleviates the bite force reduction in a mouse model of temporomandibular joint pain.

Authors:  Sang-Hyon Kim; Chang-Nam Son; Hyo-Jung Lee; Ho-Chan Cho; Sung-Won Jung; Ji An Hur; Won-Ki Baek; Hye Ra Jung; Ji Hee Hong
Journal:  J Korean Med Sci       Date:  2015-04-15       Impact factor: 2.153

4.  Elastin‑derived peptides are involved in the processes of human temporomandibular disorder by inducing inflammatory responses in synovial cells.

Authors:  Kazuhiko Kobayashi; Rei Jokaji; Mayuko Miyazawa-Hira; Shigeyuki Takatsuka; Akira Tanaka; Kazuhiro Ooi; Hiroyuki Nakamura; Shuichi Kawashiri
Journal:  Mol Med Rep       Date:  2017-07-15       Impact factor: 2.952

Review 5.  Biomarkers for Temporomandibular Disorders: Current Status and Future Directions.

Authors:  Abdalwhab Zwiri; Mohammad A I Al-Hatamleh; Wan Muhamad Amir W Ahmad; Jawaad Ahmed Asif; Suan Phaik Khoo; Adam Husein; Zuryati Ab-Ghani; Nur Karyatee Kassim
Journal:  Diagnostics (Basel)       Date:  2020-05-15

6.  Preliminary evidence for conserved transcriptional response to adversity in adults with temporomandibular disorder.

Authors:  Christopher D King; Ian A Boggero; Grant S Schulert; Hannah M Pickerill; Steve Cole
Journal:  Pain Rep       Date:  2021-01-08

7.  Effect of duloxetine in temporomandibular joint disorders: A comparison with arthrocentesis.

Authors:  Pawan Goyal; R K Singh; Shilpi Gangwar; Shadab Mohammad; U S Pal; Geeta Singh
Journal:  Natl J Maxillofac Surg       Date:  2020-12-16

Review 8.  TNF-α levels and presence of SNP-308G/A of TNF-α gene in temporomandibular disorder patients.

Authors:  Camilla Porto Campello; Elker Lene Santos de Lima; Renata Silva Melo Fernandes; Mirza Porto; Maria Tereza Cartaxo Muniz
Journal:  Dental Press J Orthod       Date:  2022-02-28

9.  A Randomized Controlled Trial Evaluating the Levels of the Biomarkers hs-CRP, IL-6, and IL-8 in Patients with Temporomandibular Disorder Treated with LLLT, Traditional Conservative Treatment, and a Combination of Both.

Authors:  Abdalwhab Ma Zwiri; Wan Muhamad Amir W Ahmad; Jawaad Ahmed Asif; Khoo Suan Phaik; Adam Husein; Nur Karyatee Kassim; Zuryati Ab-Ghani
Journal:  Int J Environ Res Public Health       Date:  2022-07-23       Impact factor: 4.614

10.  TMJ Arthrocentesis Alone and in Combination with Duloxetine in Temporomandibular Joint Pain.

Authors:  R K Singh; U S Pal; Pawan Goyal; A Nischal; Tika Ram Gurung; Dipti Daga
Journal:  J Maxillofac Oral Surg       Date:  2017-08-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.